Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Eltropag 25mg Tablet

Prescription Icon
Prescription Required

Marketer

Medicamen Biotech Ltd

Salt Composition

Eltrombopag (25mg)

Overview Eltropag 25mg Tablet

Romiplostim 25mg tablets are indicated for the management of low platelet counts stemming from chronic immune thrombocytopenic purpura (ITP) or chronic hepatitis C virus (HCV) infection. This medication also addresses severe aplastic anemia. Romiplostim 25mg is a thrombopoietin receptor agonist, functioning by boosting platelet production. Platelets are crucial for hemostasis. Adhere strictly to your physician's prescribed dosage and duration. It can be taken on an empty stomach and should be swallowed whole; avoid crushing or chewing. Report any allergies to this medication to your doctor. Common adverse reactions include nausea, vomiting, diarrhea, upper respiratory infections, and urinary tract infections. Consult your doctor if these side effects are problematic; management strategies may be available. Prior to commencing treatment, disclose any existing health issues and all other medications you are using to your doctor. Dosage modification might be necessary for patients with liver impairment.

Uses of Eltropag 25mg Tablet

Thrombocytopenia from immune thrombocytopenic purpura or hepatitis C; Management of critical aplastic anemia

Major Benefits of Eltropag 25mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Eltropag 25mg Tablet on an empty stomach.

Common Side effects of Eltropag 25mg Tablet:

  • Nausea
  • Diarrhea
  • Upper respiratory tract infection
  • Vomiting
  • Increased liver enzymes
  • Muscle pain
  • Urinary tract infection

How to use Eltropag 25mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Eltropag 25mg Tablet on an empty stomach.

How Eltropag 25mg Tablet works:

Promacta 25mg tablets function as a thrombopoietin receptor activator, prompting increased platelet production within the bloodstream. Elevated platelet levels contribute to hemostasis.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The safety of consuming alcohol while taking Eltropag 25mg Tablet is undetermined. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Eltropag 25mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The administration of Eltropag 25mg tablets while breastfeeding is likely inadvisable. Preliminary evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Driving may be impaired by Eltropag 25mg Tablets, which can induce dizziness and reduced alertness. These side effects could negatively impact your ability to operate a vehicle.

KidneyKidneySAFE IF PRESCRIBED

Eltropag 25mg tablets are considered safe for patients with kidney disease; dosage modification is typically unnecessary. Nevertheless, disclosure of kidney disease to your physician is recommended. Routine monitoring of kidney function during treatment is advisable.

LiverLiverCAUTION

Patients with liver impairment should use Eltropag 25mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Eltropag 25mg Tablet :

Omit any missed Eltropag 25mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Eltropag 25mg Tablet

LabelValue
Chemical Category Biphenyl Derivatives
Developing Habits No.
Treatment Category KINSHIP
Actions Thrombopoietin receptor activator

FAQs on Eltropag 25mg Tablet

Eltropag 25mg tablets raise blood platelet counts. Always follow your doctor's instructions for taking this medication. Swallow the tablet whole with water; do not crush or chew it.
Take Eltropag 25mg tablets precisely as your doctor directs. Administer on an empty stomach, either one hour before or two hours after a meal. Never change your dose or schedule without your doctor's explicit instruction.
Eltropag 25mg Tablets reduce bleeding risk by raising platelet counts. The onset of its effect varies individually, but typically, patients see results within two weeks.
To maximize Eltropag 25mg Tablet effectiveness, avoid dairy products (like cheese and butter) and vitamin/mineral supplements for six hours surrounding each dose—four hours beforehand and two hours afterward. Consuming these items concurrently may hinder the medication's absorption and reduce its efficacy.
Store this medication at room temperature, between 20°C and 25°C. Keep the bottle tightly closed and leave the desiccant pack inside, if included, to maintain dryness.
Eltropag 25mg Tablets can cause serious liver damage, indicated by symptoms such as jaundice (yellowing of skin and eyes), upper right abdominal pain, dark urine, and fatigue. This risk is heightened in patients with hepatitis C. The medication may also raise platelet levels, increasing the risk of blood clots, heart attack, stroke, and even death. Regular blood tests to monitor liver function and platelet count are recommended. Eltropag 25mg Tablets can also exacerbate cataracts, causing blurred vision. Report any side effects to your doctor immediately.
Missed a dose of Eltropag 25mg Tablet? Wait and take your next scheduled dose; don't double up. Taking more than one dose daily increases the risk of side effects.
Eltropag 25mg Tablet
990
MRP 1,206
17% off